Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is -116.89% as of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
Limited quarterly history available
ROIC needs at least three reported quarters before a meaningful chart is shown.
RETURN ON INVESTED CAPITAL (ROIC)
-116.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-227.93%
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.32M
Return on Invested Capital (ROIC)
-116.89%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.24M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-199.78%
3Y Avg
-1598.70%
5Y Avg
-1598.70%
Market Cap
$4.21M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$4.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-480.55%
3Y Avg
-363.38%
5Y Avg
-260.65%
Market Cap
$4.53M
Return on Invested Capital (ROIC)
-19.51%
TTM Avg
-11.65%
3Y Avg
-12.10%
5Y Avg
-17.92%
Market Cap
$4.55M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$4.63M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
Market Cap
$3.96M
Return on Invested Capital (ROIC)
-321.28%
TTM Avg
-227.99%
3Y Avg
-186.65%
5Y Avg
-145.51%
Market Cap
$4.71M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.32M | -116.89% | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.24M | N/A | -199.78% | -1598.70% | -1598.70% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.21M | -221.32% | -119.11% | -77.97% | -64.48% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | -480.55% | -363.38% | -260.65% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | -19.51% | -11.65% | -12.10% | -17.92% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | -246.61% | -463.24% | -303.42% | -359.05% |
| CalciMedica, Inc. (CALC)vs › | $4.63M | -122.56% | -179.66% | -275.36% | -182.57% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.96M | -321.28% | -227.99% | -186.65% | -145.51% |
| Imunon, Inc. (IMNN)vs › | $4.71M | -126.69% | -289.57% | -198.60% | -147.26% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | -288.14% | -190.86% | -162.44% | -129.35% |
ROIC
-116.9%
ROE
-184.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -116.89% |